Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol TCI combined with different doses of etomidate for painless gastrointestinal endoscopy
ChiCTR2100044884Phase 4Recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propofol and etomidate in gastrointestinal conditions (3 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoints: blood pressure and concentration of propofol. Started Mar 2021; status: recruiting.
02
Drugs
propofoletomidate
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2100044884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044884.